Deciphering the Arterial and Venous Blood Bacterial DNA Profile: Pioneering Insights into Coronary Heart Disease

Mengru Liu1, Lin Zhao1, Tianli Li1

  • 1Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.

Microorganisms
|February 27, 2026
PubMed

Insights

This study explored bacterial profiles in coronary heart disease (CHD) patients, finding distinct microbial communities in arterial versus venous blood. Further research is needed to confirm these findings in larger patient groups.

Area of Science:

  • Microbiology
  • Cardiovascular Science

Background:

  • Coronary heart disease (CHD) is a major global health concern.
  • The gut microbiota is implicated in CHD development, but bacterial translocation remains difficult to quantify.
  • Understanding bacterial presence in circulation is key to atherosclerosis research.

Purpose of the Study:

  • To investigate systemic bacterial profiles in patients with coronary heart disease (CHD).
  • To compare microbial diversity and richness between arterial and venous blood fractions.
  • To explore the potential role of bacterial translocation in CHD pathogenesis.

Main Methods:

  • 16S rRNA-based metagenomic analysis was performed on blood samples from 27 CHD patients.
  • Microbial diversity was compared between plasma and serum.
  • Differences in microbial richness were assessed across arterial and venous whole blood, plasma, and serum.

Main Results:

  • Higher microbial diversity was observed in plasma compared to serum.
  • Significant differences in microbial richness were found across various blood fractions (arterial/venous, whole blood/plasma/serum).
  • Detected bacterial taxa were consistent with intestinal, oral, or skin microbiota origins.

Conclusions:

  • Preliminary evidence suggests distinct bacterial profiles in arterial versus venous blood fractions of CHD patients.
  • Findings indicate potential bacterial presence in systemic circulation.
  • Larger, controlled studies are required to validate these preliminary results due to the small sample size and lack of a control group.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
815
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
649
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
479
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
651
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338